Click here to visit Company website

Intercell USA discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free patch technology. The vaccine patch aims at enhancing the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The currently leading product candidates in development are a patch to prevent Travelers' Diarrhea and Pandemic Flu immunostimulant patch.